The study revealed that [152Tb]Tb-PSMA-617 and [177Lu]Lu-PSMA-617 exhibited similar pharmacokinetic profiles in tumor-bearing mice, which was consistent with previous in vitro findings 89. This evidence concerns the gene FOLH1 and neoplasm.